Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-04-06Clinical Trial Update: Study of RAD001 in Patients With Relapsed/Refractory Hodgkin Lymphoma That Has Progressed After High-dose Chemotherapy and Autologous Stem Cell Transplant and/or After Gemcitabine- or Vinorelbine- or Vinblastine-based Treatment. [Phase 2]
Phase 2 study of everolimus (RAD001) in relapsed/refractory Hodgkin lymphoma after high-dose chemotherapy/autologous stem cell transplant or…
-
CLINICAL_TRIALS trial_result · 2016-03-28Clinical Trial Update: Bortezomib and Gemcitabine Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating bortezomib plus gemcitabine hydrochloride in relapsed or refractory Hodgkin lymphoma has completed and posted resul…
-
CLINICAL_TRIALS trial_result · 2016-02-26Clinical Trial Update: Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating safety and efficacy of POL6326 for mobilization and transplant in hematologic malignancies has completed…
-
CLINICAL_TRIALS trial_result · 2016-02-26Clinical Trial Update: Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer [Phase 2]
Phase 2 trial update of Basiliximab to prevent graft-versus-host disease after nonmyeloablative allogeneic transplantation in blood cancers;…
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Study of Ofatumumab and ESHAP for the Treatment of Hodgkin's Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating the combination of ofatumumab with the ESHAP regimen for Hodgkin lymphoma has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-02-09Clinical Trial Update: A Phase 1 Study in Patients With Relapsed or Refractory Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma [Phase 1]
This document reports Phase 1 results from a trial in relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma. T…
-
CLINICAL_TRIALS trial_result · 2016-02-01Clinical Trial Update: Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed or Refractory Hodgkin's Lymphoma [Phase 2]
This Phase 2 trial assesses the combination of chemotherapy and radiation therapy in patients undergoing autologous stem cell transplant for…
-
CLINICAL_TRIALS trial_result · 2016-01-25Clinical Trial Update: Chemotherapy Plus Radiation Therapy in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma [Phase 2]
This Phase 2 trial studied the combination of chemotherapy plus radiation therapy for patients with refractory or relapsed Hodgkin lymphoma,…
-
CLINICAL_TRIALS trial_result · 2016-01-14Clinical Trial Update: Total Body Irradiation/Fludarabine Based Ablative Haploidentical Transplant for Hematologic Diseases [Phase 2]
Phase 2 trial evaluating total body irradiation with fludarabine-based conditioning followed by haploidentical transplantation for hematolog…
-
CLINICAL_TRIALS trial_result · 2016-01-08Clinical Trial Update: Efficacy Study of Outpatient Therapy for Lymphoma [Phase 2]
A Phase 2 efficacy trial evaluating outpatient therapy for lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-01-08Clinical Trial Update: MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma [Phase 1]
Phase 1 trial update for MORAb-004 in young patients with recurrent or refractory solid tumors or lymphoma; the study has been completed.
-
CLINICAL_TRIALS trial_result · 2015-12-28Clinical Trial Update: Spectroscopy With Surface Coils and Decoupling [Phase 1]
A Phase 1 clinical trial evaluating spectroscopy with surface coils and decoupling has completed, across multiple cancer indications. Sponso…
-
CLINICAL_TRIALS trial_result · 2015-12-24Clinical Trial Update: Safety and Efficacy of Idelalisib in Relapsed or Refractory Hodgkin Lymphoma [Phase 2]
Phase 2 trial assessing safety and efficacy of idelalisib in relapsed or refractory Hodgkin lymphoma has completed with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2015-12-23Clinical Trial Update: A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942) [Phase 2]
A Phase 2 trial in pediatric Hodgkin lymphoma evaluating chemotherapy for all patients with optional low-dose involved-field irradiation; th…
-
CLINICAL_TRIALS trial_result · 2015-12-18Clinical Trial Update: Tacrolimus/Sirolimus/Methotrexate vs Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With Lymphoma [Phase 3]
Phase 3 randomized trial comparing tacrolimus/sirolimus/methotrexate to tacrolimus/methotrexate or cyclosporine/mycophenolate mofetil for GV…
-
CLINICAL_TRIALS trial_result · 2015-12-17Clinical Trial Update: Use of FDG PET as Predictor of Residual Disease and Subsequent Relapse in Patients With NHL and HD Undergoing HDC and ASCT [NA]
This completed clinical trial evaluates whether FDG PET imaging can predict residual disease. It also examines subsequent relapse in patient…
-
CLINICAL_TRIALS trial_result · 2015-12-17Clinical Trial Update: Cytogenetic Analysis of Bone Marrow Specimen Prior to High Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease [NA]
ClinicalTrials.gov update indicates completion of a study assessing cytogenetic analysis of bone marrow before high-dose chemotherapy and au…
-
CLINICAL_TRIALS trial_result · 2015-12-07Clinical Trial Update: Anti-Tac(90 Y-HAT) to Treat Hodgkin's Disease, Non-Hodgkin's Lymphoma and Lymphoid Leukemia [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating Anti-Tac labeled with Yttrium-90 (90Y-HAT) for Hodgkin lymphoma, Non-Hodgkin lymphoma, and lymphoid leuk…
-
CLINICAL_TRIALS trial_result · 2015-12-04Clinical Trial Update: Bortezomib in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma [Phase 2]
Phase 2 study of bortezomib in adults with relapsed or refractory Hodgkin lymphoma has completed enrollment and the trial status is reported…
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Mozobil for Autologous Stem Cell Mobilization [Phase 2]
Phase 2 trial update for Mozobil (plerixafor) assessing autologous stem cell mobilization has completed in Non-Hodgkin's Lymphoma and Hodgki…
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Safety Study of the Proteasome Inhibitor PR-171 (Carfilzomib for Injection) in Patients With Hematological Malignancies [Phase 1]
Phase 1 safety study of carfilzomib (PR-171) in hematologic malignancies has completed and results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: MELT - MRI Evaluation of Lymphoma Treatment
A completed clinical trial (MELT) assessing MRI evaluation of treatment response in Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: PVAG-14 Pilot for Intermediate Stages Hodgkin Lymphoma [Phase 2]
A Phase 2 clinical trial of PVAG-14 for intermediate-stage Hodgkin lymphoma sponsored by the University of Cologne has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-11-24Clinical Trial Update: A Study Of Panobinostat In Children With Refractory Hematologic Malignancies [Phase 1]
This update reports the completion of a Phase 1 pediatric study evaluating panobinostat in children with refractory hematologic malignancies…
-
CLINICAL_TRIALS trial_result · 2015-11-13Clinical Trial Update: Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies [Phase 2]
Phase 2 study evaluating a triple regimen of vorinostat, tacrolimus, and methotrexate to prevent graft-versus-host disease after allogeneic …